Ernexa Therapeutics Inc.: Form 10-Q for the period ended Mar 31, 2017
Filed with the SEC on May 4, 2017 and accepted by EDGAR at May 4, 2017, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-01-01 to 2017-03-31 | $5.2m | us-gaap:Revenues |
| Selling, general and administrative | 3 months2017-01-01 to 2017-03-31 | $4.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-01-01 to 2017-03-31 | −$834.0k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-01-01 to 2017-03-31 | $6.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-01-01 to 2017-03-31 | −$90.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-01-01 to 2017-03-31 | −$0.04 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months2017-01-01 to 2017-03-31 | −$466.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2017-01-01 to 2017-03-31 | $97.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2017-03-31 | $6.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-03-31 | $11.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-03-31 | $17.5m | us-gaap:Assets |
| Current liabilities | At period end2017-03-31 | $10.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-03-31 | $11.7m | us-gaap:Liabilities |
| Current portion of debt | At period end2017-03-31 | $7.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2017-03-31 | $5.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-17-004743. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.